The project, "Biological Pathways and Next-Generation Imaging Features Predicting Prostate Cancer Progression in Active Surveillance," coordinated by Dr. Giorgio Gandaglia, a researcher at URI and Vita-Salute San Raffaele University, has received My First AIRC Grant (MFAG24) funding. This study aims to identify innovative imaging-based biological mechanisms and biomarkers to improve the selection of patients with low-risk prostate cancer who are candidates for active surveillance. Through the integration of innovative methods including genomics, spatial transcriptomics, immunohistochemistry, and imaging with PET/MRI with PSMA, it aims to develop a predictive model to personalize treatments, reduce unnecessary biopsies, and tailor the treatment pathway.
Dr. Giorgio Gandaglia
Urologist at the Operating Unit of Urology, IRCCS San Raffaele Hospital
Coordinator of the prostate cancer group of the Young Academic Urologists Working Parties of the EAU
